EU Parliament agrees on pharmaceutical legislation stance

Website EUR Affairs Pharmaceutical Legislation

On April 10, the European Parliament adopted its position on the revision of the EU pharmaceutical legislation.

Read more

Cancer Medicines Forum workshop April 5: a way forward for treatment optimizatio…

martin kaiser headshot

The Cancer Medicines Forum (CMF) is hosted by the European Medicines Agency (EMA) in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC).

Read more

EHA-ECL led statement calls for protection of the Hospital Exemption

EUR Affairs Hospital Exemption 1920 x 1080 px 1

The hospital exemption (HE) is a vital provision within the EU's pharmaceutical legislation, currently subject to a revision.

Read more

Helping to shape Europe’s clinical trials landscape: EHA selected for ACT EU adv…

EHA joins ACT EU advisory board image

Improving the design, efficiency and effectiveness of clinical trials is the objective of the Accelerating Clinical Trials in the European Union (ACT EU) initiative.

Read more

Belgium shares EU health priorities for Council Presidency

EHA Newsblog Belgium EU Council Presidency

On December 8, Belgium held a conference to unveil its program for the upcoming Council of the EU Presidency (website), to start on January 1, 2024.

Read more

EHA response to the EU’s Pharma Revision

Last week, the European Affairs team finalised EHA's response to the proposed revision of the EU (European Union) Pharmaceutical Legislation.

Read more

Hematology and oncology, pacemakers for EU HTA

EAA HTA panel with M Kaiser

EHA’s Martin Kaiser, right, addressing his fellow panelists. Left to right: Brian Cuffel (Bayer), Caroline Pothet (EMA), Roisin Adams (HTA CG), Bernhard Wörmann (DGHO) and Elisabeth de Vries (ESMO).

Read more

Strengthening Resilience and Fostering Collaboration: Ensuring a Transparent and…

Plasma

The issue of immunoglobulin shortages and the importance of enhancing and maintaining plasma supplies have gained significant attention within the policy and regulatory landscape of the European Union.

Read more

New HemaSphere publication on IVDR implementation

Hema logo

The In Vitro Diagnostic medical devices Regulation (IVDR), which came in to force in May 2022 with the objective of safeguarding the quality and safety of diagnostic tests in the EU,…

Read more

Moldova to be allowed to participate in EU4Health projects

eu4health logo

The European Commission and the Government of the Republic of Moldova have signed an agreement to associate Moldova with the EU4Health program.

Read more

EU calls for proposal 2023

AdobeStock 353450686

IntroductionHorizon Europe is the research and innovation programme of the EU for the period 2021-2027.

Read more

EHA supports the proposal for a Regulation on the European Health Data Space (EH…

Healthcare stakeholders statement SM post

On October 20, the European Hematology Association (EHA) joined a group of 35 stakeholders in welcoming the European Commission’s proposal on the European Health Data Space.

Read more

EHA in EU-funded project on voluntary plasma collection capacity in Europe

Plasma

EHA to participate in an EU-funded project on “Strengthening voluntary non-remunerated plasma collection capacity in Europe” (SUPPLY) Context: Plasma shortage  Plasma-derived medicinal products (PDMPs) are used to treat a variety of rare,…

Read more

EHA to the European Commission and HTA leaders: work with medical societies to i…

20220622 HTA Conference speakers

The speakers of the HTA conference hosted by the European Commission.

Read more

New EU In Vitro Diagnostic medical devices Regulation (IVDR) comes into effect

EHA Studio 4

On May 26, 2022, the new EU In Vitro Diagnostic medical devices Regulation (IVDR) came into effect, mandating stricter and more comprehensive certification and testing protocols for in vitro diagnostic…

Read more